SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-275062
Filing Date
2022-11-01
Accepted
2022-11-01 17:17:45
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d400450ds3.htm S-3 398140
2 EX-1.2 d400450dex12.htm EX-1.2 196463
3 EX-4.5 d400450dex45.htm EX-4.5 275036
4 EX-4.6 d400450dex46.htm EX-4.6 287042
5 EX-5.1 d400450dex51.htm EX-5.1 15851
6 EX-5.2 d400450dex52.htm EX-5.2 9442
7 EX-23.1 d400450dex231.htm EX-23.1 2440
8 EX-FILING FEES d400450dexfilingfees.htm EX-FILING FEES 53688
9 GRAPHIC g400450g04p63.jpg GRAPHIC 35402
10 GRAPHIC g400450g1101095656365.jpg GRAPHIC 2751
  Complete submission text file 0001193125-22-275062.txt   1285950
Mailing Address 85 BOLTON STREET CAMBRIDGE MA 02140
Business Address 85 BOLTON STREET CAMBRIDGE MA 02140 (617)500-8864
Aura Biosciences, Inc. (Filer) CIK: 0001501796 (see all company filings)

IRS No.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-268105 | Film No.: 221351487
SIC: 2836 Biological Products, (No Diagnostic Substances)